News Posts List
Kidney cancer drug gets go-ahead
02/04/2009
The NHS drugs watchdog NICE has in principle approved a kidney cancer drug which can increase survival by a year. Sunitinib is one of the first drugs to be approved under new guidance urging a more liberal approach to treatments which only marginally extend life.
Merck open to acquiring major competitor, CEO says
02/04/2009
Merck & Co. is not ruling out purchasing a major drugmaker as it looks "across the whole spectrum" of options, CEO Richard Clark said.
Pfizer Discontinues Global Phase III Trial Of Axitinib
02/02/2009
"These results were disappointing, given the trend towards prolonged survival seen in a Phase II study of axitinib in this extremely difficult-to-treat patient population,"
Roche makes hostile bid for Genentech
02/01/2009
Swiss drugmaker Roche Holding reduced its acquisition offer for Genentech from $89 to $86.50 a share after negotiations with the biotech firm failed.
Medarex says FDA approves testing of cancer drug
01/29/2009
MDX-1203 contains an antibody that targets a protein called CD70, which is found in leukemia, lymphoma, renal cell carcinoma and other cancers.
Lorus Therapeutics Publishes Study Demonstrating LOR-2040 Improves Anticancer Effects of Interferon in Kidney Cancer
01/28/2009
The article entitled "GTI-2040 Displays Cooperative Anti-Tumor Activity when Combined with Interferon alpha against Human Renal Carcinoma Xenografts" was published in the International Journal of Oncology (2009, Vol. 34: 33-42).
ZymoGenetics Secures Worldwide Rights to IL-21
01/28/2009
Securing rest of world IL-21 rights supports our strategy of seeking a global partner for this oncology asset, and were pleased to have accomplished this without near-term cash outlays, said Heather Franklin, Senior Vice President, Business Development. In the first half of this year, we plan to present Phase 2 results in renal cell carcinoma and metastatic melanoma.
Medicare Widens Drugs It Accepts for Cancer
01/27/2009
Medicare, with little public debate, has expanded its coverage of drugs for cancer treatments not approved by the Food and Drug Administration.
Type of Diet Does Not Increase Risk of Renal Cell Cancer
01/27/2009
Researchers involved in an international study have reported that intake of fat, red meat, processed meat, poultry, or seafood is not associated with risk of renal cell cancer.
The Obama Cancer Plan Should Prioritize Prevention, According To The Cancer Prevention Coalition
01/26/2009
Disturbingly no reference is made to prevention, and the wide range of avoidable causes of cancer.
News Feed